Phar­maEssen­tia se­cures $462M+ to fur­ther growth of Besre­mi and its pipeline

Phar­maEssen­tia an­nounced an of­fer­ing of 34 mil­lion shares of its com­mon stock, pulling in $462.7 mil­lion in the process.

On Fri­day, the Tai­wanese phar­ma com­pa­ny …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER